Sukumaran SC, Sarma PS, Thomas SV. Polytherapy increases the risk of infertility in women with epilepsy (CME). Neurology. 2010;75(15):1351–5.
Pennell PB, French JA, Harden CL, Davis A, Bagiella E, Andreopoulos E, et al. Fertility and birth outcomes in women with epilepsy seeking pregnancy. JAMA Neurol. 2018;75(8):962.
PubMed PubMed Central Article Google Scholar
Larsen MD, Jølving LR, Fedder J, Nørgård BM. The efficacy of assisted reproductive treatment in women with epilepsy. Reprod Biomed Online. 2020;41(6):1015–22.
Mostacci B, Esposto R, Lello S, Bisulli F, Licchetta L, Tinuper P. Estrogen-related seizure exacerbation following hormone therapy for assisted reproduction in women with epilepsy. Seizure. 2018;61:200–2.
Battino D, Tomson T, Bonizzoni E, Craig J, Lindhout D, Sabers A, et al. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry. Epilepsia. 2013;54(9):1621–7.
CAS PubMed Article Google Scholar
Sanjeev VT, Unnikrishnan S, Sucharitha DJ. Predictors of seizures during pregnancy in women with epilepsy. Epilepsia. 2012;53(5):e85–8.
•• Pennell PB, French JA, May RC, Gerard E, Kalayjian L, Penovich P, et al. Changes in seizure frequency and antiepileptic therapy during pregnancy. New Engl J Med. 2020;383(26):2547–56. This study reveals that, when undergoing therapeutic drug monitoring, pregnant women have similar risk of seizure worsening as non-pregnant women; thus, pregnancy in itself does not increase the risk for seizures, but it alters medication clearance.
Vajda FJE, O’Brien TJ, Graham J, Lander CM, Eadie MJ. The outcomes of pregnancy in women with untreated epilepsy. Seizure. 2015;24:7781.
Vajda FJE, Brien TJO, Graham JE, Hitchcock AA, Perucca P, Lander CM, et al. The control of treated generalized and focal epilepsies during pregnancy. Epilepsy Behav. 2021;125: 108406.
Voinescu EP, Ehlert AN, Bay CP, Allien S, Pennell PB. Variations in seizure frequency during pregnancy and postpartum by epilepsy type. Neurology. 2021. https://doi.org/10.1212/WNL.0000000000013056.
Mostacci B, Troisi S, Bisulli F, Zenesini C, Licchetta L, Provini F, et al. Seizure worsening in pregnancy in women with sleep-related hypermotor epilepsy (SHE): a historical cohort study. Seizure. 2021;91:258–62.
Teramo K, Hiilesmaa V, Bardy A, Saarikoski S. Fetal heart rate during a maternal grand mal epileptic seizure. J Perinat Med. 1978;7(1):3–6.
Sahoo S, Klein P. Maternal complex partial seizure associated with fetal distress. Arch Neurol-chicago. 2005;62(8):1304–5.
Rauchenzauner M, Ehrensberger M, Prieschl M, Kapelari K, Bergmann M, Walser G, et al. Generalized tonic–clonic seizures and antiepileptic drugs during pregnancy—a matter of importance for the baby? J Neurol. 2013;260(2):484–8.
CAS PubMed Article Google Scholar
Chen YHH, Chiou HYY, Lin HCC, Lin HLL. Affect of seizures during gestation on pregnancy outcomes in women with epilepsy. Arch Neurol. 2009;66(8):979–84.
Pennell P, Peng L, Newport D, Ritchie J, Koganti A, Holley D, et al. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology. 2007;70(22 Pt 2):2130–6.
Reisinger T, Newman M, Loring D, Pennell P, Meador K. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy & behavior : E&B. 2013;29(1):13–8.
Voinescu P, Park S, Chen L, Neurology SZ. Antiepileptic drug clearances during pregnancy and clinical implications for women with epilepsy. 2018.
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17(6):530–8.
CAS PubMed Article Google Scholar
• Meador KJ, Cohen MJ, Loring DW, May RC, Brown C, Robalino CP, et al. Two-year-old cognitive outcomes in children of pregnant women with epilepsy in the maternal outcomes and neurodevelopmental effects of antiepileptic drugs study. Jama Neurol. 2021;78(8):927–36. Emerging neurodevelopmental data at age 2 on newer antiseizure medications is reassuring, though it raises the concern for a dose-dependent effects on different developmental scores. Upcoming analyses of neurodevelopmental scores at older ages will clarify these initial findings.
• Pennell PB, Karanam A, Meador KJ, Gerard E, Kalayjian L, Penovich P, et al. Antiseizure medication concentrations during pregnancy. Jama Neurol. 2022;79(4). Study detailing the magnitude and time course of pregnancy-related clearance changes for many antiseizure medications used preferentially to treat women during reproductive years.
Voinescu P, Park S, Chen LQ, Stowe ZN, Newport D, Ritchie JC, et al. Antiepileptic drug clearances during pregnancy and clinical implications for women with epilepsy. Neurology. 2018;91(13):e1228–36.
CAS PubMed PubMed Central Article Google Scholar
Johnson EL, Stowe ZN, Ritchie JC, Newport JD, Newman ML, Knight B, et al. Carbamazepine clearance and seizure stability during pregnancy. Epilepsy Behav. 2014;33:4953.
Tomson T, Landmark CJ, Battino D. Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications. Epilepsia. 2013;54(3):405–14.
CAS PubMed Article Google Scholar
Tomson T, Lindbom U, Ekqvist B, Sundqvist A. Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin. Epilepsia. 1994;35(1):122–30.
CAS PubMed Article Google Scholar
Landmark C, Farmen A, Burns M, Baftiu A, Lossius MI, Johannessen SI, et al. Pharmacokinetic variability of valproate during pregnancy – implications for the use of therapeutic drug monitoring. Epilepsy Res. 2018;141:31–7.
Reimers A, Helde G, Andersen N, Aurlien D, Navjord E, Haggag K, et al. Zonisamide serum concentrations during pregnancy. Epilepsy Res. 2018.
Tomson T, Battino D, Bromley R, Kochen S, Meador K, Pennell P, et al. Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy. Epileptic Disord. 2019;21(6):497–517.
Veroniki A, Cogo E, Rios P, Straus SE, Finkelstein Y, Kealey R, et al. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med. 2017;15(1):95.
PubMed PubMed Central Article Google Scholar
Hernandez-Diaz S, Smith C, Shen A, Mittendorf R, Hauser W, Yerby M, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology. 2012;78(21):1692–9.
CAS PubMed Article Google Scholar
Keni RR, Jose M, Sarma PS, Thomas SV, Group KR of E and PS. Teratogenicity of antiepileptic dual therapy: Dose-dependent, drug-specific, or both? Neurology. 2017;90(9):e790–6.
Campbell E, Devenney E, Morrow J, Russell A, Smithson WH, Parsons L, et al. Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero. Epilepsia. 2012;54(1):165–71.
Reinisch JM, Sanders SA, Mortensen EL, Rubin DB. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA. 1995;274(19):1518–25.
CAS PubMed Article Google Scholar
Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009;360(16):1597–605.
CAS PubMed PubMed Central Article Google Scholar
Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, et al. Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology. 2012;78(16):1207–14.
Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. The Lancet Neurology. 2013;12(3):244–52.
CAS PubMed PubMed Central Article Google Scholar
Baker GA, Bromley RL, Briggs M, Cheyne CP, Cohen MJ, García-Fiñana M, et al. IQ at 6 years after in utero exposure to antiepileptic drugs. Neurology. 2015;84(4):382–90.
CAS PubMed PubMed Central Article Google Scholar
Christensen J, Grønborg T, Sørensen M, Schendel D, Parner E, Pedersen L, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013;309(16):1696–703.
CAS PubMed PubMed Central Article Google Scholar
Bromley RL, Calderbank R, Cheyne CP, Rooney C, Trayner P, Clayton-Smith J, et al. Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate. Neurology. 2016;87(18):1943–53.
CAS PubMed Article Google Scholar
Shallcross R, Bromley R, Irwin B, Bonnett L, Morrow J, Baker G, et al. Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology. 2011;76(4):383–9.
CAS PubMed PubMed Central Article Google Scholar
Bjørk M, Riedel B, Spigset O, Veiby G, Kolstad E, Daltveit A, et al. Association of folic acid supplementation during pregnancy with the risk of autistic traits in children exposed to antiepileptic drugs in utero. JAMA Neurology. 2017.
Soontornpun A, Choovanichvong T, Tongsong T. Pregnancy outcomes among women with epilepsy: a retrospective cohort study. Epilepsy Behav. 2018;82:52–6.
Hernández-Díaz S, McElrath TF, Pennell PB, Hauser WA, Yerby M, Holmes LB, et al. Fetal growth and premature delivery in pregnant women on antiepileptic drugs. Ann Neurol. 2017;82(3):457–65.
Tomson T, Battino D, Bonizzoni E, Craig JJ, Lindhout D, Perucca E, et al. Antiepileptic drugs and intrauterine death: a prospective observational study from EURAP. Neurology. 2015;85(7):580–8.
CAS PubMed Article Google Scholar
Victora CG, Bahl R, Barros AJD, França GVA, Horton S, Krasevec J, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387(10017):475–90.
Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, et al. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr. 2014;168(8):729–36.
Comments (0)